Yüklüyor......
Bromodomain and extraterminal (BET) protein inhibition of IgG/IgE production in murine B cells is counter‐balanced by a strong Th2 bias
OBJECTIVES: Inhibitors of bromodomain and extra terminal domain (BET) proteins are a new and growing class of anti‐cancer drugs, which decrease oncogene expression by targeting superenhancers. Antibody production is another physiological process relying on superenhancers, and it remains to be clarif...
Kaydedildi:
| Yayımlandı: | Clin Transl Immunology |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8164936/ https://ncbi.nlm.nih.gov/pubmed/34136216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1280 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|